Načítá se...
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.
Uloženo v:
| Vydáno v: | Mol Cell Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816412/ https://ncbi.nlm.nih.gov/pubmed/31692823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2019.1650631 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|